"COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions (PCC) among high-risk patients at a Federally Qualified Health Center" "The prevalence of PCC was high among this patient population following COVID-19 mAb treatment" http
RT @Jenn030303: US study The prevalence of Post COVID conditions was high among the patient population following COVID-19 mAb treatment. Ti…
US study The prevalence of Post COVID conditions was high among the patient population following COVID-19 mAb treatment. Time to mAb infusion did not predict the development of LC https://t.co/RPSUy8ZmWA
mAbs the rough with the smooth Good results in acute care Little evidence of a positive impact on post acute sequelae Feck feck feckitty feck feck https://t.co/WYBbhTpcFy